FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Moderna Quits CMV Vaccine After Phase 3 Failure

[ Price : $8.95]

Moderna stops the development of its congenital cytomegalovirus vaccine after it failed to meet the primary endpoint in a large Ph...

3rd Patient-Focused Drug Development Guidance

[ Price : $8.95]

FDA publishes the third in a series of guidances on aspects of collecting patient experience data to be used in medical product de...

QS, MDR, UDI Issues in Levo AG Inspection

[ Price : $8.95]

FDA warns Switzerlands Levo AG about Quality System, Medical Device Reporting, and Unique Device Identifier violations in its prod...

Repeat CGMP Violations at Guangxi Yulin

[ Price : $8.95]

A 3/17-3/21 FDA inspection at the Guangxi Yulin Pharmaceutical Group drug manufacturing facility in Yulin, Guangxi, China, found r...

FDA Orphan Status for Netherton Syndrome Drug

[ Price : $8.95]

FDA grants Quoin Pharmaceuticals an orphan drug designation for QRX003 and its use in treating Netherton syndrome.

Genentechs Gazyva Approved for Lupus Nephritis

[ Price : $8.95]

FDA approves Genentechs Gazyva (obinutuzumab) for treating adult patients with active lupus nephritis who are receiving standard t...

Major Staff Losses at CDER and CBER Amid Shake-up

[ Price : $8.95]

FDA releases hiring data showing steep declines in staffing at CDER and CBER.

CGMP Violations Seen in BRS Services Inspection

[ Price : $8.95]

FDA warns St. Louis, MO-based BRS Analytical Services about CGMP violations in its production of finished drugs.

GSK and Speros Antibiotic Positive Phase 3 Results

[ Price : $8.95]

GSK and Spero Therapeutics report positive Phase 3 results for tebipenem HBr, an investigational oral antibiotic for complicated u...

FDA Strengthens Tranexamic Acid Warning

[ Price : $8.95]

FDA says it is strengthening labeling for tranexamic acid injection products to clarify that it is only to be administered intrave...